Matches in UGent Biblio for { <https://biblio.ugent.be/publication/4351732#aggregation> ?p ?o. }
Showing items 1 to 45 of
45
with 100 items per page.
- aggregation classification "A1".
- aggregation creator B832642.
- aggregation creator B832643.
- aggregation creator B832644.
- aggregation creator B832645.
- aggregation creator B832646.
- aggregation creator B832647.
- aggregation creator B832648.
- aggregation creator B832649.
- aggregation creator B832650.
- aggregation creator B832651.
- aggregation creator B832652.
- aggregation creator B832653.
- aggregation creator person.
- aggregation date "2013".
- aggregation format "application/msword".
- aggregation hasFormat 4351732.bibtex.
- aggregation hasFormat 4351732.csv.
- aggregation hasFormat 4351732.dc.
- aggregation hasFormat 4351732.didl.
- aggregation hasFormat 4351732.doc.
- aggregation hasFormat 4351732.json.
- aggregation hasFormat 4351732.mets.
- aggregation hasFormat 4351732.mods.
- aggregation hasFormat 4351732.rdf.
- aggregation hasFormat 4351732.ris.
- aggregation hasFormat 4351732.txt.
- aggregation hasFormat 4351732.xls.
- aggregation hasFormat 4351732.yaml.
- aggregation isPartOf urn:issn:1464-2662.
- aggregation language "eng".
- aggregation rights "I have transferred the copyright for this publication to the publisher".
- aggregation subject "Medicine and Health Sciences".
- aggregation title "Stability of hepatitis C virus (HCV) RNA levels among interferon-naïve HIV/HCV-coinfected individuals treated with combination antiretroviral therapy".
- aggregation abstract "Objectives: Infection with hepatitis C virus (HCV) is a major cause of chronic liver disease. High HCV RNA levels have been associated with poor treatment response. This study aimed to examine the natural history of HCV RNA in chronically HCV/HIV-coinfected individuals. Methods: Mixed models were used to analyse the natural history of HCV RNA changes over time in HIV-positive patients with chronic HCV infection. Results: A total of 1541 individuals, predominantly White (91%), male (73%), from southern (35%) and western central Europe (23%) and with HCV genotype 1 (58%), were included in the analysis. The median follow-up time was 5.0 years [interquartile range (IQR) 2.8 to 8.3 years]. Among patients not on combination antiretroviral therapy (cART), HCV RNA levels increased by a mean 27.6% per year [95% confidence interval (CI) 6.1-53.5%; P=0.0098]. Among patients receiving cART, HCV RNA levels were stable, increasing by a mean 2.6% per year (95% CI -1.1 to 6.5%; P=0.17). Baseline HCV RNA levels were 25.5% higher (95% CI 8.8 to 39.1%; P=0.0044) in individuals with HCV genotype 1 compared with HCV genotypes 2, 3 and 4. A 1 log HIV-1 RNA copies/mL increase in HIV RNA was associated with a 10.9% increase (95% CI 2.3 to 20.2%; P=0.012) in HCV RNA. Conclusions: While HCV RNA levels increased significantly in patients prior to receiving cART, among those treated with cART HCV RNA levels remained stable over time.".
- aggregation authorList BK1206930.
- aggregation endPage "378".
- aggregation issue "6".
- aggregation startPage "370".
- aggregation volume "14".
- aggregation aggregates 4351745.
- aggregation aggregates 4353509.
- aggregation isDescribedBy 4351732.
- aggregation similarTo hiv.12033.
- aggregation similarTo LU-4351732.